Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | +6.59% | -2.48% | +52.78% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 33.33M | Capitalization | 106M |
---|---|---|---|---|---|
Net income 2024 * | -47M | Net income 2025 * | -33M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.18 x |
P/E ratio 2024 * |
-2.44
x | P/E ratio 2025 * |
-4.41
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.5% |
Latest transcript on Eledon Pharmaceuticals, Inc.
1 day | +6.59% | ||
1 week | -2.48% | ||
1 month | +20.09% | ||
3 months | +70.81% | ||
6 months | +141.23% | ||
Current year | +52.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-04-30 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 21-03-14 |
Steven Perrin
PSD | President | 59 | 20-09-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 17-04-30 |
Walter Ogier
BRD | Director/Board Member | 67 | 20-09-13 |
John McBride
BRD | Director/Board Member | 72 | 17-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.75 | +6.59% | 118,501 |
24-05-30 | 2.58 | +7.50% | 101,146 |
24-05-29 | 2.4 | -6.98% | 108,615 |
24-05-28 | 2.58 | -8.51% | 247,956 |
24-05-24 | 2.82 | -2.42% | 189,162 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.78% | 106M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ELDN Stock